EUVIMEDEUVIMED entdecken
Open Access

Targeting splicing factors for cancer therapy

Ariel Bashari iD, Zahava Siegfried iD, Rotem Karni iD

RNA · 2023

DOI: 10.1261/rna.079585.123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RNA, 2023. Verfasst von Ariel Bashari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, the Institute for Medical Research Israel-Canada, Hebrew University Hadassah Medical School, Jerusa…. Hauptthemen laut MEDLINE: RNA Splicing, Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alternative splicing (AS) of mRNAs is an essential regulatory mechanism in eukaryotic gene expression. AS misregulation, caused by either dysregulation or mutation of splicing factors, has been shown to be involved in cancer development and progression, making splicing factors suitable targets for cancer therapy. In recent years, various types of pharmacological modulators, such as small molecules and oligonucleotides, targeting distinct components of the splicing machinery, have been under development to treat multiple disorders. Although these approaches have promise, targeting the core spliceosome components disrupts the early stages of spliceosome assembly and can lead to nonspecific and toxic effects. New research directions have been focused on targeting specific splicing factors for a more precise effect. In this Perspective, we will highlight several approaches for targeting splicing factors and their functions and suggest ways to improve their specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA SplicingNeoplasmsHumansRNA Splicing FactorsAlternative SplicingSpliceosomes

Stichwörter der Autor:innen

cancer therapydecoy oligonucleotidessmall moleculessplicingsplicing factor

Substanzen

RNA Splicing Factors

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, the Institute for Medical Research Israel-Canada, Hebrew University Hadassah Medical School, Jerusalem 9112001, Israel.
  • Department of Biochemistry and Molecular Biology, the Institute for Medical Research Israel-Canada, Hebrew University Hadassah Medical School, Jerusalem 9112001, Israel rotemka@ekmd.huji.ac.il.

ORCID-Profile: Ariel Bashari, Zahava Siegfried, Rotem Karni

Zitieren

APA

Bashari, A., Siegfried, Z., & Karni, R. (2023). Targeting splicing factors for cancer therapy. RNA. https://doi.org/10.1261/rna.079585.123

Vancouver

Bashari A, Siegfried Z, Karni R. Targeting splicing factors for cancer therapy. RNA. 2023. doi:10.1261/rna.079585.123

BibTeX
@article{Bashari2023,
  author = {Bashari, Ariel and Siegfried, Zahava and Karni, Rotem},
  title = {Targeting splicing factors for cancer therapy},
  journal = {RNA},
  year = {2023},
  doi = {10.1261/rna.079585.123}
}
Kostenlos starten →